Made possible by charitable contributions from Accuray , Advanced Accelerator Applications , Clovis Oncology , and Dendreon . Thank You!

Navigation Tip: Click on blue text that’s underlined and in bold for link to more information.


We hope that you are doing well and enjoying the holiday season. As 2019 comes to a close, we look ahead to the New Year with the enclosed January 2020 issue of the Hot SHEET .

We’d like to thank everyone who has donated to the Us TOO Holiday Hope fundraising campaign. And if you’ve not yet done so, please consider a contribution t o help support the work that we do at Us TOO providing educational resources, support services and personal connections to the prostate cancer community at no charge. 

Video is now available from the Us TOO Prostate Cancer Pathways event and webcast presented in Chicago on November 9. Prostate cancer medical experts covered various topics identified as most important to men with prostate cancer, based on recent survey responses from Us TOO support group leaders. Presentations and panel discussions featured: Nelson Bennett, Jr., MD; Maha Hussain, MD, FACP, FASCO; Shilajit D. Kundu, MD; Alicia Morgans, MD, MPH; Sean Sachdev, MD; David J. VanderWeele, MD, PhD; Genetic Counselor Carmen Williams . Topics that were   addressed included Active Surveillance, Surgical Options & Side Effects, Prostate Cancer Radiotherapy, Prostate Cancer & the Penis, Prostate Cancer Patient Perspective, Genetics & Prostate Cancer, Advanced Prostate Cancer, Genomic/Molecular Testing & Bone Strength . Video content is labeled by specific topics for each segment for quick and easy access to brief segments or the entire webcast .

Rick Davis and our friends at AnCan have launched a new peer-led virtual group for Under-60 Men with Advanced Prostate Cancer . The group meets the 2nd Thursday of every month at 7:00 pm Eastern. In the U.S., join the conference call by dialing (646) 749-3129 , and use access code: 222-583-973 ; CLICK HERE for more information, including international phone numbers.

In addition to volunteering his leadership with the Us TOO prostate cancer support group in Las Vegas, Tony Crispino has been working with ASCO (American Society of Clinical Oncology) over the last year on molecular biomarkers for prostate cancer , which has led to the release of a new guideline featured in the Journal of Clinical Oncology . This content helps address questions about the use of molecular tests in the treatment of prostate cancer. Thank you, Tony!

On behalf of a market research company, Us TOO is providing a paid survey opportunity for prostate cancer patients and caregivers with advancing disease . Qualified respondents who complete the survey in its entirety will be eligible to receive $50 from the market research company paid via check within four weeks. The survey should take no longer than 20-25 minutes to complete. Please note that you will need to finish this study in one sitting. If you do not, please wait for an email from Elizabeth Lawson with a unique link to continue where you left off in the survey. The company will also make a donation to Us TOO. This is for US residents only at this time. CLICK HERE to take the survey.

We wish you all the best in 2020. Let us know how we can help provide you with Us TOO educational resources, support services and personal connections to others in the prostate cancer community. 

Happy New Year!

Chuck Strand, Chief Executive Officer
James Hutson, Development Director
Jackie Konieczka, Office Manager
Terri Likowski, Program Director - Support Group Services
Tim Mix, Communications Director